[DOI] [PubMed] [Google Scholar] 354.Gane EJ, Lo SK, Riordan SM, Portmann BC, Lau JY, Naoumov NV, et al
doi:10.1210/jcem-63-2-412 Kasagi K, Iwata M, Misaki T, Konishi J
Our cagrilintide and semaglutide guide provides a detailed breakdown of the CagriSema data
Estos hallazgos son especialmente importantes dado que muchos pacientes con diabetes tipo 2 tienen un riesgo elevado de complicaciones cardiovasculares
The treatment typically starts at a low dose and is increased over several weeks or months to help your body adjust and minimize potential side effects
Schedule an appointment online with a general practitioner near you or call us at 623-334-4000 for additional information